External validity of phase III trials on vaccines against SARS-CoV-2 to a middle-aged and elderly Western European population

Initial results from various phase-III trials on vaccines against SARS-CoV-2 are promising. For proper translation of these results to clinical guidelines, it is essential to determine how well the general population is reflected in the study populations of these trials. This study was conducted amo...

Descripción completa

Detalles Bibliográficos
Autores principales: Terzikhan, Natalie, Hofman, Albert, Goudsmit, Jaap, Ikram, Mohammad Arfan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906827/
https://www.ncbi.nlm.nih.gov/pubmed/33634346
http://dx.doi.org/10.1007/s10654-021-00729-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7906827/
https://www.ncbi.nlm.nih.gov/pubmed/33634346
http://dx.doi.org/10.1007/s10654-021-00729-5

Ejemplares similares